AFP and hepatocellular carcinoma: In cirrhotic surveillance, ultrasound alone detects early-stage HCC with a sensitivity of ~47% (95% CI 33–61%), improving to ~63% when AFP is added, but with reduced specificity; pooled sensitivity for detecting any-stage HCC is ~84% for both ultrasound and CT/MRI in surveillance contexts [27].